Home NDC 0071-0737 Lopid
Product NDC 0071-0737
11-digit product format 000710737
Labeler code 0071
Product ID 0071-0737_ef2b3c7e-b287-4cae-9bc3-86fb6ccbe9ae
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name gemfibrozil
Dosage form TABLET, FILM COATED
Route ORAL
Labeler Parke-Davis Div of Pfizer Inc
Application NDA018422
Marketing category NDA
Marketing start 2004-03-30
Marketing end 0000-00-00
Substance GEMFIBROZIL
Active strength 600 mg/1
Pharmacologic classes Peroxisome Proliferator-activated Receptor alpha Agonists [MoA],PPAR alpha [CS],Peroxisome Proliferator Receptor alpha Agonist [EPC]
NDC exclude flag No
Listing certified through 2021-12-31
Current FDA listing Historical FDA.report record
Source provenance: Browse the complete Orange Book source catalog · source snapshot 44 .
Orange Book products# Current product rows page 1 of 1 · 3 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N018422-001 LOPID GEMFIBROZIL 200MG CAPSULE / ORAL Approved before 1982 N018422-002 LOPID GEMFIBROZIL 300MG CAPSULE / ORAL Approved before 1982 N018422-003 LOPID GEMFIBROZIL 600MG TABLET / ORAL AB RLD, RS 1986-11-20
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 1 matching rows.
Application-product, TE code table Application-product TE code N018422-003 AB
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 4 · 132 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-10-15 13:18:30 2026-09 N018422-001 LOPID 200MG CAPSULE / ORAL Approved before 1982 c2088c7a36db…2026-10-15 13:18:30 2026-09 N018422-002 LOPID 300MG CAPSULE / ORAL Approved before 1982 c2088c7a36db…2026-10-15 13:18:30 2026-09 N018422-003 LOPID 600MG TABLET / ORAL AB RLD, RS 1986-11-20 c2088c7a36db…2026-09-14 22:38:34 2026-08 N018422-001 LOPID 200MG CAPSULE / ORAL Approved before 1982 84e616aacf4f…2026-09-14 22:38:34 2026-08 N018422-002 LOPID 300MG CAPSULE / ORAL Approved before 1982 84e616aacf4f…2026-09-14 22:38:34 2026-08 N018422-003 LOPID 600MG TABLET / ORAL AB RLD, RS 1986-11-20 84e616aacf4f…2026-08-18 06:07:40 2026-07 N018422-001 LOPID 200MG CAPSULE / ORAL Approved before 1982 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N018422-002 LOPID 300MG CAPSULE / ORAL Approved before 1982 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N018422-003 LOPID 600MG TABLET / ORAL AB RLD, RS 1986-11-20 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N018422-001 LOPID 200MG CAPSULE / ORAL Approved before 1982 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N018422-002 LOPID 300MG CAPSULE / ORAL Approved before 1982 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N018422-003 LOPID 600MG TABLET / ORAL AB RLD, RS 1986-11-20 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N018422-001 LOPID 200MG CAPSULE / ORAL Approved before 1982 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N018422-002 LOPID 300MG CAPSULE / ORAL Approved before 1982 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N018422-003 LOPID 600MG TABLET / ORAL AB RLD, RS 1986-11-20 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N018422-001 LOPID 200MG CAPSULE / ORAL Approved before 1982 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N018422-002 LOPID 300MG CAPSULE / ORAL Approved before 1982 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N018422-003 LOPID 600MG TABLET / ORAL AB RLD, RS 1986-11-20 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N018422-001 LOPID 200MG CAPSULE / ORAL Approved before 1982 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N018422-002 LOPID 300MG CAPSULE / ORAL Approved before 1982 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N018422-003 LOPID 600MG TABLET / ORAL AB RLD, RS 1986-11-20 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N018422-001 LOPID 200MG CAPSULE / ORAL Approved before 1982 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N018422-002 LOPID 300MG CAPSULE / ORAL Approved before 1982 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N018422-003 LOPID 600MG TABLET / ORAL AB RLD, RS 1986-11-20 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N018422-001 LOPID 200MG CAPSULE / ORAL Approved before 1982 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N018422-002 LOPID 300MG CAPSULE / ORAL Approved before 1982 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N018422-003 LOPID 600MG TABLET / ORAL AB RLD, RS 1986-11-20 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N018422-001 LOPID 200MG CAPSULE / ORAL Approved before 1982 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N018422-002 LOPID 300MG CAPSULE / ORAL Approved before 1982 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N018422-003 LOPID 600MG TABLET / ORAL AB RLD, RS 1986-11-20 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N018422-001 LOPID 200MG CAPSULE / ORAL Approved before 1982 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N018422-002 LOPID 300MG CAPSULE / ORAL Approved before 1982 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N018422-003 LOPID 600MG TABLET / ORAL AB RLD, RS 1986-11-20 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N018422-001 LOPID 200MG CAPSULE / ORAL Approved before 1982 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N018422-002 LOPID 300MG CAPSULE / ORAL Approved before 1982 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N018422-003 LOPID 600MG TABLET / ORAL AB RLD, RS 1986-11-20 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N018422-001 LOPID 200MG CAPSULE / ORAL Approved before 1982 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N018422-002 LOPID 300MG CAPSULE / ORAL Approved before 1982 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N018422-003 LOPID 600MG TABLET / ORAL AB RLD, RS 1986-11-20 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N018422-001 LOPID 200MG CAPSULE / ORAL Approved before 1982 79d66fd596c7…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 2 · 44 observed states.
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 0071-0737-20 Lopid 60 in 1 BOTTLE TABLET, FILM COATED 60 23 0071-0737-30 Lopid 500 in 1 BOTTLE TABLET, FILM COATED 500 23
DailyMed Socrata Ingredients# Ingredient, Type, UNII table Ingredient Type UNII DailyMed label SPL version Uploaded gemfibrozil ACTIVE INGREDIENT Q8X02027X3 LOPID (GEMFIBROZIL) TABLET, FILM COATED [PARKE-DAVIS DIV OF PFIZER INC] 11 gemfibrozil ACTIVE MOIETY Q8X02027X3 LOPID (GEMFIBROZIL) TABLET, FILM COATED [PARKE-DAVIS DIV OF PFIZER INC] 11 CALCIUM STEARATE INACTIVE INGREDIENT 776XM7047L LOPID (GEMFIBROZIL) TABLET, FILM COATED [PARKE-DAVIS DIV OF PFIZER INC] 11 CANDELILLA WAX INACTIVE INGREDIENT WL0328HX19 LOPID (GEMFIBROZIL) TABLET, FILM COATED [PARKE-DAVIS DIV OF PFIZER INC] 11 CELLULOSE, MICROCRYSTALLINE INACTIVE INGREDIENT OP1R32D61U LOPID (GEMFIBROZIL) TABLET, FILM COATED [PARKE-DAVIS DIV OF PFIZER INC] 11 HYDROXYPROPYL CELLULOSE (TYPE H) INACTIVE INGREDIENT RFW2ET671P LOPID (GEMFIBROZIL) TABLET, FILM COATED [PARKE-DAVIS DIV OF PFIZER INC] 11 HYPROMELLOSES INACTIVE INGREDIENT 3NXW29V3WO LOPID (GEMFIBROZIL) TABLET, FILM COATED [PARKE-DAVIS DIV OF PFIZER INC] 11 METHYLPARABEN INACTIVE INGREDIENT A2I8C7HI9T LOPID (GEMFIBROZIL) TABLET, FILM COATED [PARKE-DAVIS DIV OF PFIZER INC] 11 POLYETHYLENE GLYCOLS INACTIVE INGREDIENT 3WJQ0SDW1A LOPID (GEMFIBROZIL) TABLET, FILM COATED [PARKE-DAVIS DIV OF PFIZER INC] 11 POLYSORBATE 80 INACTIVE INGREDIENT 6OZP39ZG8H LOPID (GEMFIBROZIL) TABLET, FILM COATED [PARKE-DAVIS DIV OF PFIZER INC] 11 PROPYLPARABEN INACTIVE INGREDIENT Z8IX2SC1OH LOPID (GEMFIBROZIL) TABLET, FILM COATED [PARKE-DAVIS DIV OF PFIZER INC] 11 SILICON DIOXIDE INACTIVE INGREDIENT ETJ7Z6XBU4 LOPID (GEMFIBROZIL) TABLET, FILM COATED [PARKE-DAVIS DIV OF PFIZER INC] 11
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 0071-0737 LOPID (GEMFIBROZIL) TABLET, FILM COATED [PARKE-DAVIS DIV OF PFIZER INC] 22 Legacy NDC, 2 package rows 20240716_c48855b7-215e-453b-b3b1-a0f9dee7221f.zip
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Marketing start Marketing end Sample Exclude flag Status 0071-0737-20 00071073720 60 TABLET, FILM COATED in 1 BOTTLE (0071-0737-20) 2004-03-30 0000-00-00 No No Current 0071-0737-30 00071073730 500 TABLET, FILM COATED in 1 BOTTLE (0071-0737-30) 2004-03-30 0000-00-00 No No Current